3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Heart -

Exercise Test May Predict Death in Patients with Coronary Artery Disease

HeartNov 14, 05

Exercise capacity, as measured in terms of VO2max, is a powerful predictor of death in patients with coronary artery disease, not just patients with heart failure. That is the finding of Mayo Clinic research presented today at the American Heart Association’s Scientific Sessions 2005 in Dallas.

VO2max is the maximum amount of oxygen a person can take in during exercise. In a VO2max study, a patient walks on a treadmill for about 5 to 15 minutes and breathes through a valve; the oxygen and carbon dioxide in the expired air are measured. Results are given in milliliters of oxygen per kilogram of body weight per minute (ml/kg/min).

“The best predictor of survival in cardiac patients is their capacity for exercise,” says Thomas Allison, Ph.D., the lead author of the study, who is from Mayo Clinic in Rochester, Minn. “When we considered all of the measurable clinical variables—such as whether they had bypass surgery or whether they have diabetes or high blood pressure—the patient’s capacity for exercise as measured by VO2max stood clear as the best predictor for 10-year survival.”

In this study, the significance of low VO2max levels was examined in patients with coronary artery disease—the top cause of death in the United States and often a precursor to a heart attack and heart failure.

A group of 282 patients, 17 percent of them women, underwent cardiopulmonary treadmill testing at the end of cardiac rehabilitation and were followed for an average of 9.8 years. The average age was 61 at the time of the test.

In the first two years there were few deaths, but after that mortality was significantly higher in patients with low VO2max. Fifty-five patients had a low VO2max (less than 18 ml/kg/min); at 10 years, almost half (42 percent) had died. Of the 227 patients who had a VO2max above or equal to 18 ml/kg/min, only 11.6 percent had died at the 10-year mark. Even after adjusting for age, sex and ventricular function, VO2max was a strong predictor of mortality.

The results confirm that poor functional capacity—specifically a VO2max of less than 18 ml/kg/min—is a major predictor of long-term mortality, even in a group of cardiac rehabilitation patients with good medical management, close follow-up and excellent short-term prognosis.

“This research suggests that physicians should strongly consider looking at VO2max for heart patients, not just those with heart failure, and help them preserve their exercise capacity,” Dr. Allison says. “Patients can do things, too, like exercising regularly and losing weight, to maintain their VO2max.

“It remains to be seen whether improving VO2max through better medical care or surgical intervention versus weight loss and a better exercise program will be the key to improving survival, but we suspect both are important,” he says.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New superfoods could help key protein keep bodies healthy
  Mobile app on emergency cardiac care aids best decisions in seconds
  Train your heart to protect your mind
  Mass. General study identifies path to safer drugs for heart disease, cancer
  Tweaking MRI to track creatine may spot heart problems earlier, Penn Medicine study suggests
  Method to estimate LDL-C may provide more accurate risk classification
  Texting heart medication reminders improved patient adherence
  Hybrid heart valve is strong, durable in early tests
  Cardiopoietic ‘Smart’ Stem Cells Show Promise in Heart Failure Patients
  Vitamin D deficiency ups heart disease risk
  Heart surgery safe in Jehovah’s Witnesses
  Magnet helps target transplanted iron-loaded cells to key areas of heart

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site